The role of human decay-accelerating factor in the pathogenesis of preterm labor

American Journal of Perinatology

Volumn 28, Issue 7, 2011, Pages 565-570

  Pacheco, Luis D ^a   Hankins, Gary D ^a   Costantine, Maged M ^a   Anderson, Garland D ^a   Pawelczyk, Edyta ^c   Nowicki, Stella ^b   Nowicki, Bogdan J ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

complement activation; decay accelerating factor; Preterm labor

Indexed keywords

DECAY ACCELERATING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELL KINETICS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; PATHOGENESIS; PREMATURE LABOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA ISOLATION; UPREGULATION;

ADULT; ANTIGENS, CD55; COMPLEMENT ACTIVATION; FEMALE; GESTATIONAL AGE; HUMANS; LEUKOCYTES; OBSTETRIC LABOR, PREMATURE; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION; YOUNG ADULT;

EID: 79960836834     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0031-1274510     Document Type: Article

References (17)

1. Hamilton B E., Martin J A., Ventura S J. Births: preliminary data for 2007. Natl Vital Stat Rep 2009 57 1-23
2. ACOG Committee on Practice Bulletins. American College of Obstetricians and Gynecologist. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor. Obstet Gynecol 2003 101 5 Pt 1 1039-1047
3. Joseph K S., Kramer M S., Marcoux S et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998 339 1434-1439 (Pubitemid 28516066)
4. Rooney I A., Morgan B P. Non-lethal doses of antibody and complement stimulate release of prostaglandin E2 from human amniotic cells in vitro. Biochem Soc Trans 1990 18 617 (Pubitemid 20249591)
5. Holl I, Handzo I, Dolezalov S, Ponecov M, Krlov M, Huckov M. Immunologic parameters in women with threatened premature labor. Cesk Gynekol 1993 58 176-179
6. Elimian A, Figueroa R, Canterino J, Verma U, Aguero-Rosenfeld M, Tejani N. Amniotic fluid complement C3 as a marker of intra-amniotic infection. Obstet Gynecol 1998 92 72-76 (Pubitemid 28285324)
7. Brodbeck W G., Kuttner-Kondo L, Mold C, Medof M E. Structure/function studies of human decay-accelerating factor. Immunology 2000 101 104-111
8. Hasan R J., Pawelczyk E, Urvil P T. et al. Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect Immun 2002 70 4485-4493 (Pubitemid 34790960)
9. Lublin D M., Coyne K E. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J Exp Med 1991 174 35-44
10. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993 151 1562-1570 (Pubitemid 23219294)
11. Cunningham D S., Tichenor J R. Jr. Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin Immunol Immunopathol 1995 74 156-161
12. Holmes C H., Simpson K L., Wainwright S D. et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990 144 3099-3105 (Pubitemid 20149486)
13. Xu C, Mao D, Holers V M., Palanca B, Cheng A M., Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000 287 498-501
14. Nowicki S, Izban M G., Pawelczyk E et al. Preterm labor: CD55 in maternal blood leukocytes. Am J Reprod Immunol 2009 61 360-367
15. Kaul A, Nagamani M, Nowicki B. Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am J Reprod Immunol 1995 34 236-240
16. Btis F, Brest P, Hofman V et al. Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr adhesins. Infect Immun 2003 71 1774-1783 (Pubitemid 36368706)
17. Blok V T., Gelderman K A., Tijsma O H., Daha M R., Gorter A. Cytokines affect resistance of human renal tumour cells to complement-mediated injury. Scand J Immunol 2003 57 591-599 (Pubitemid 36735000)